Kris MG - Search Results

1

Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung Cancer.

Arbour KC, Rizvi H, Plodkowski AJ, Hellmann MD, Knezevic A, Heller G, Yu HA, Ladanyi M, Kris MG, Arcila ME, Rudin CM, Lito P, Riely GJ. Arbour KC, et al. Among authors: kris mg. Clin Cancer Res. 2021 Apr 15;27(8):2209-2215. doi: 10.1158/1078-0432.CCR-20-4023. Epub 2021 Feb 8. Clin Cancer Res. 2021. PMID: 33558425 Free PMC article.

2

Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients.

Grant SC, Gralla RJ, Kris MG, Orazem J, Kitsis EA. Grant SC, et al. Among authors: kris mg. J Clin Oncol. 1992 Mar;10(3):484-98. doi: 10.1200/JCO.1992.10.3.484. J Clin Oncol. 1992. PMID: 1311028

3

Induction chemotherapy for non-small cell lung cancer with clinically evident mediastinal node metastases: the role of postoperative radiotherapy.

Armstrong JG, Martini N, Kris MG, Harrison LB. Armstrong JG, et al. Among authors: kris mg. Int J Radiat Oncol Biol Phys. 1992;23(3):605-13. doi: 10.1016/0360-3016(92)90018-d. Int J Radiat Oncol Biol Phys. 1992. PMID: 1319427 Clinical Trial.

4

A reappraisal of the role of prophylactic cranial irradiation in limited small cell lung cancer.

Rosenstein M, Armstrong J, Kris M, Shank B, Scher H, Fass D, Harrison L, Fuks Z, Leibel S. Rosenstein M, et al. Int J Radiat Oncol Biol Phys. 1992;24(1):43-8. doi: 10.1016/0360-3016(92)91019-j. Int J Radiat Oncol Biol Phys. 1992. PMID: 1324901 Clinical Trial.

5

Limited small-cell lung cancer: do favorable short-term results predict ultimate outcome?

Armstrong J, Shank B, Scher H, Gaynor J, Martini N, Kutcher J, Kris M. Armstrong J, et al. Am J Clin Oncol. 1991 Aug;14(4):285-90. Am J Clin Oncol. 1991. PMID: 1650527

6

Phase II trial of esorubicin (4'deoxydoxorubicin, DxDx) in patients with small cell lung cancer.

Rigas JR, Kris MG, Gralla RJ, Heelan RT, Marks LD. Rigas JR, et al. Among authors: kris mg. Invest New Drugs. 1991 May;9(2):187-90. doi: 10.1007/BF00175087. Invest New Drugs. 1991. PMID: 1651908 Clinical Trial.

7

Twice daily thoracic irradiation for limited small cell lung cancer.

Armstrong JG, Rosenstein MM, Kris MG, Shank BM, Scher HI, Fass DE, Harrison LB, Leibel SA, Fuks ZY. Armstrong JG, et al. Among authors: kris mg. Int J Radiat Oncol Biol Phys. 1991 Oct;21(5):1269-74. doi: 10.1016/0360-3016(91)90285-c. Int J Radiat Oncol Biol Phys. 1991. PMID: 1657842 Clinical Trial.

8

Limited small cell lung cancer: prognostic significance of a complete response to the induction phase of chemotherapy followed by thoracic irradiation.

Armstrong JG, Rosenstein MM, Scher HI, Fass DE, Zelefsky MJ, Kris MG. Armstrong JG, et al. Among authors: kris mg. Radiology. 1991 Mar;178(3):875-8. doi: 10.1148/radiology.178.3.1847240. Radiology. 1991. PMID: 1847240 Clinical Trial.

9

Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer.

Berger MZ, Kris MG, Gralla RJ, Marks LD, Potanovich LM, Dimaggio JJ, Heelan RT. Berger MZ, et al. Among authors: kris mg. Am J Clin Oncol. 1991 Apr;14(2):124-6. doi: 10.1097/00000421-199104000-00006. Am J Clin Oncol. 1991. PMID: 1851387

10

Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung cancer.

Kris MG, D'Acquisto RW, Gralla RJ, Burke MT, Marks LD, Fanucchi MP, Heelan RT. Kris MG, et al. Am J Clin Oncol. 1989 Feb;12(1):24-6. doi: 10.1097/00000421-198902000-00006. Am J Clin Oncol. 1989. PMID: 2536213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters